0
No products in the cart.
Cart
Total:
£
0.00
Home
Competencies
Services
Epi Data
Team
Home
Competencies
Services
Epi Data
Team
Overview of Kymriah (CAR-T therapy) by Novartis in ALL
£
9.99
Overview of Kymriah (CAR-T therapy) by Novartis in ALL
Add to cart
Category:
digital
Tags:
acute lymphoblastic leukemia
,
acute lymphocytic leukemia
,
CAR-T
,
CAR-T therapy
,
Kymriah
,
Novartis
Share on:
Description
Overview of
Kymriah
(CAR-T therapy) by Novartis in ALL
Slides in the pack:
Kymriah (
tisagenlecleucel)
from Novartis
Pricing
Epidemiology- Acute
Lymphoblastic
Leukemia
(ALL)
Mechanism of action of various treatments for ALL
Other treatments for
acute
lymphoblastic leukemia
Related products
Add to cart
Overview of CAR-T therapies
£
19.99
Add to cart
The Atopic Dermatitis market and the approval of Dupixent
£
29.99
Add to cart
Overview: Luxturna by Spark Therapeutics
£
19.99
Add to cart
An overview of RNAi therapies
£
19.99